Resultados de búsqueda - Isabel Manger

Increased serum NfL and GFAP levels indicate different subtypes of neurologic immune‐related adverse events during treatment with immune checkpoint inhibitors Autoría: Christina Schmitt, Katharina J. Müller, Steffen Tiedt, Nora Kramer, Isabel Manger, Samuel Knauss, Leonie Müller‐Jensen, Petra Huehnchen, Wolfgang Boehmerle, Florian Schöberl, Lucie Heinzerling, Louisa von Baumgarten